Company intelligence / Profile preview

CoapTech

Baltimore, Maryland, United States

Ownership: Private
Development stage: Commercial

Overview

The FDA-cleared PUMA-G System is the first and only ultrasound-based solution for bedside feeding tube placement. Clinical studies have demonstrated significant reductions in ICU and hospital length of stay, as well as per-patient hospital costs. The system has been validated in live human patients across multiple care settings and shows lower complication rates compared to traditional methods.

Therapeutic areas: Gastroenterology
Modalities: DeviceMedical device (ultrasound-guided, magnet-aligned catheter systems)
Industry: Surgical Medical Devices

Partnerships

LaunchPort LLC (manufacturing accelerator)

Beyond the preview

Go deeper on CoapTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CoapTech.

Explore the full profile